L1 Global Manager’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

L1 Global Manager’s Portfolio BCTXW Stock Details BCTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,000	Closed	-$370	–	119
2025 Q4	$370	Buy	+7,000	New	+$349	﹤0.01%	93

L1 Global Manager's BCTXW Position: Q1 2026 in Review

L1 Global Manager sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q1 2026, closing a stake of 7,000 shares — an estimated $370 sold.

L1 Global Manager first reported a position in BCTXW in Q4 2025 and held it in 1 quarter. The position peaked at $370 in Q4 2025. 0 funds tracked by Wall St. Rank hold BCTXW as of Q1 2026.

L1 Global Manager reported no remaining BriaCell Therapeutics Corp Warrant position as of Q1 2026 after selling out during the quarter.
L1 Global Manager sold 7,000 BriaCell Therapeutics Corp Warrant shares in Q1 2026, an estimated $370.
L1 Global Manager first reported a position in BriaCell Therapeutics Corp Warrant in Q4 2025 and held it in 1 quarter.
L1 Global Manager's BriaCell Therapeutics Corp Warrant position peaked at $370 in Q4 2025.
0 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q1 2026.

Based on L1 Global Manager's 13F filing for Q1 2026, filed 15 May 2026.